Article ID Journal Published Year Pages File Type
8399447 Mitochondrion 2014 7 Pages PDF
Abstract
We demonstrate for the first time low myocardial CoQ10 in cardiomyopathy in PA, highlighting secondary mitochondrial impairment as a relevant causative mechanism. According to these findings, a high-dose CoQ10 supplementation could be a potential adjuvant therapeutic to be considered in PA-related cardiomyopathy.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biophysics
Authors
, , , , , , , , , , , , , ,